Alessandro Blasimme

Cited by

	All	Since 2019
Citations	4265	3742
h-index	28	25
i10-index	53	46

1000

500

250

750

20132014201520162017201820192020202120222023202421 47 50 87 110 160 238 334 514 763 994 879

Public access

View all

36 articles

1 article

available

not available

Based on funding mandates

Co-authors

Effy VayenaETH ZurichVerified email at hest.ethz.ch
Marco CanevelliDepartment of Human Neuroscience, Sapienza University, Rome, ItalyVerified email at uniroma1.it
Giuseppe BrunoProfessore Associato, Università "Sapienza", RomaVerified email at uniroma1.it
Marcello IencaTechnical University of Munich (TUM)Verified email at tum.de
Matteo CesariWorld Health OrganizationVerified email at who.int
"Glenn Cohen" "I.G. Cohen" "I. Glenn...Harvard Law SchoolVerified email at law.harvard.edu
Bastian Greshake TzovarasSenior Researcher @ Alan Turing Institute & Director of Open HumansVerified email at turing.ac.uk
Pierre-Luc GermainUniversity & ETH ZürichVerified email at hest.ethz.ch
Alessandro CuomoIEOVerified email at ieo.it
Pasquale LaiseSenior Director of Single-Cell Systems Biology at DarwinHealth Inc.Verified email at darwinhealth.com
Giulia FragolaUNC at Chapel HillVerified email at med.unc.edu
paola piscopoRicercatore, Istituto Superiore di Sanità, RomaVerified email at iss.it
Annamaria ConfaloniPrimo Ricercatore, Istituto Superiore di SanitàVerified email at iss.it
Giuseppina TalaricoDipartimento di Neuroscienze Umane - Università "Sapienza", RomaVerified email at uniroma1.it
Paolo MaugeriEuropean Institute of Oncology - University of MilanVerified email at ieo.eu
Lisa BortolottiProfessor of Philosophy, University of BirminghamVerified email at bham.ac.uk
Tiziana BonaldiTenured Group Leader European Institute of OncologyVerified email at ieo.it
gabriele bucciIRCCS Ospedale San RaffaeleVerified email at hsr.it
Cesar SommerAllogene TherapeuticsVerified email at allogene.com
Stefano CasolaFIRC Institute of Molecular Oncology, IFOMVerified email at ifom.eu

Alessandro Blasimme

ETH Zurich

Verified email at hest.ethz.ch

Bioethics


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Explainability for artificial intelligence in healthcare: a multidisciplinary perspective J Amann, A Blasimme, E Vayena, D Frey, VI Madai, ... BMC medical informatics and decision making 20, 1-9, 2020	1078	2020
Machine learning in medicine: addressing ethical challenges E Vayena, A Blasimme, IG Cohen PLoS medicine 15 (11), e1002689, 2018	612	2018
Digital health: meeting the ethical and policy challenges E Vayena, T Haeusermann, A Adjekum, A Blasimme Swiss medical weekly 148, w14571, 2018	197	2018
Elements of trust in digital health systems: scoping review A Adjekum, A Blasimme, E Vayena Journal of medical Internet research 20 (12), e11254, 2018	145	2018
Operational definition of active and healthy ageing (AHA): a conceptual framework J Bousquet, D Kuh, M Bewick, T Standberg, J Farrell, R Pengelly, ME Joel, ... The journal of nutrition, health & aging 19, 955-960, 2015	136	2015
Biomedical big data: new models of control over access, use and governance E Vayena, A Blasimme Journal of bioethical inquiry 14, 501-513, 2017	135	2017
Health research with big data: time for systemic oversight E Vayena, A Blasimme The journal of law, medicine & ethics 46 (1), 119-129, 2018	121	2018
Data sharing for precision medicine: policy lessons and future directions A Blasimme, M Fadda, M Schneider, E Vayena Health Affairs 37 (5), 702-709, 2018	99	2018
Mapping the translational science policy ‘valley of death’ EM Meslin, A Blasimme, A Cambon-Thomsen Clinical and translational medicine 2, 1-8, 2013	96	2013
What's next for COVID-19 apps? Governance and oversight A Blasimme, E Vayena Science 370 (6518), 760-762, 2020	87	2020
Open sharing of genomic data: Who does it and why? T Haeusermann, B Greshake, A Blasimme, D Irdam, M Richards, ... PLoS One 12 (5), e0177158, 2017	82	2017
Cell reprogramming requires silencing of a core subset of polycomb targets G Fragola, PL Germain, P Laise, A Cuomo, A Blasimme, F Gross, ... PLoS genetics 9 (2), e1003292, 2013	79	2013
Ethics review of big data research: What should stay and what should be reformed? A Ferretti, M Ienca, M Sheehan, A Blasimme, ES Dove, B Farsides, ... BMC medical ethics 22 (1), 51, 2021	71	2021
Becoming partners, retaining autonomy: ethical considerations on the development of precision medicine A Blasimme, E Vayena BMC Medical Ethics 17 (67), 2016	67	2016
Big data and dementia: charting the route ahead for research, ethics, and policy M Ienca, E Vayena, A Blasimme Frontiers in medicine 5, 13, 2018	66	2018
Operational definition of active and healthy aging (AHA): the European innovation partnership (EIP) on AHA reference site questionnaire: Montpellier October 20–21, 2014, Lisbon … J Bousquet, J Malva, M Nogues, LR Mañas, B Vellas, J Farrell, M Bewick, ... Journal of the American Medical Directors Association 16 (12), 1020-1026, 2015	66	2015
Digital contact tracing against COVID-19 in Europe: current features and ongoing developments A Blasimme, A Ferretti, E Vayena Frontiers in Digital Health 3, 660823, 2021	65	2021
The ethics of AI in biomedical research, patient care and public health A Blasimme, E Vayena Patient Care and Public Health (April 9, 2019). Oxford Handbook of Ethics of …, 2019	61	2019
Familial Alzheimer's disease sustained by presenilin 2 mutations: Systematic review of literature and genotype–phenotype correlation M Canevelli, P Piscopo, G Talarico, N Vanacore, A Blasimme, A Crestini, ... Neuroscience & Biobehavioral Reviews 42, 170-179, 2014	61	2014
Democratizing health research through data cooperatives A Blasimme, E Vayena, E Hafen Philosophy & Technology 31, 473-479, 2018	56	2018

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors